Novome

formerly NOVOME BIOTECHNOLOGIES, INC.Closed

South San Francisco, United States · Founded 2016 · $76.5M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$76.5M
Last Round
$43.5M Series BSep 2022
Rounds
3

About

Novome Biotechnologies developed genetically engineered microbial medicines (GEMMs), engineered strains of gut bacteria designed to perform defined therapeutic activities in the human gastrointestinal tract to treat chronic diseases. Its lead program was a therapeutically engineered, orally administered bacterial cell therapy for enteric hyperoxaluria, aimed at reducing oxalate levels linked to kidney stones and kidney disease, and it partnered with Genentech to apply its GEMM platform. Founded in 2016 by scientists from Stanford University and UC Berkeley and based in South San Francisco, California, the company wound down operations in August 2023.

Summary

Novome is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $76.5M in total across 3 rounds, most recently a $43.5M Series B round in Sep 2022. Investors include Tencent, DCVC (Data Collab) and 5AM Ventures.

Funding History

Series BSeries BSep 2022
$43.5M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Novome on Indexed.vc
<a href="https://indexed.vc/companies/novome"><img src="https://indexed.vc/api/badge/company/novome" alt="Novome on Indexed.vc" width="260" height="76" /></a>